SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 29, 2003
MEDSOURCE TECHNOLOGIES, INC.
- --------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
Delaware 000-49702 52-2094496
-------- --------- ----------
(State or Other Jurisdiction (Commission File No.) (IRS Employer
of Incorporation) Identification No.)
110 Cheshire Lane, Suite 100, Minneapolis, MN 55305
- --------------------------------------------- -----
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code (952) 807-1234
Item 9. Regulation FD Disclosure.
------------------------
The following information is being provided under Item 12 of Form
8-K, "Results of Operations and Financial Condition". Attached as Exhibit 99.1
is an earnings release with respect to the registrant's financial results for
the quarter ended March 30, 2003.
Exhibits.
Exhibit No. Description
----------- -----------
99.1 Press Release of the registrant dated April 29, 2003.
SIGNATURE
---------
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Date: April 29, 2003
MEDSOURCE TECHNOLOGIES, INC.
By: /s/ William J. Kullback
---------------------------------
William J. Kullback
Senior Vice President - Finance
and Chief Financial Officer
EXHIBIT INDEX
Exhibit No. Description
----------- -----------
99.1 Press Release of the registrant dated April 29, 2003.